Skip to Content

MYLAN 6726 MYLAN 6726 (Zonisamide 50 mg)

Pill imprint MYLAN 6726 MYLAN 6726 has been identified as Zonisamide 50 mg.

Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zonisamide 50 mg MYLAN 6726 MYLAN 6726
Zonisamide 50 mg MYLAN 6726 MYLAN 6726 Front
Zonisamide 50 mg MYLAN 6726 MYLAN 6726 Back
Zonisamide 50 mg MYLAN 6726 MYLAN 6726
MYLAN 6726 MYLAN 6726
50 mg
Purple / White
15.00 mm
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
magnesium stearate
microcrystalline cellulose
propylene glycol
sodium lauryl sulfate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0749 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.